The proposed sale is small (0.05% of market cap) and by a former officer, not current management. No material negative read-through. Monitor for actual Form 4 filings to confirm execution, but this filing alone does not signal distress or deteriorating fundamentals.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Jun 10 $35.48entry
- T+1 · 5mo ago −0.79%α −2.49% · $35.20
- T+5 · 5mo ago −4.65%α −8.08% · $33.83
- T+20 · 4mo ago +7.69%α +4.07% · $38.21
- T+60 · due 2mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell up to 27,960 shares (~$943K at recent prices), acquired via cash exercise of options. The sale is routine and proportional relative to the $1.9B market cap, representing a small fraction of typical insider holdings.
Key Facts
- Sandip Kapadia (former officer) intends to sell 27,960 shares of HRMY common stock.
- Approximate value ~$943,264 based on filing.
- Shares acquired via exercise of options under a registered plan on June 5, 2026.
- Sale intended for June 9, 2026 on Nasdaq.
- This is intent to sell, not a completed sale.
- Three prior sales by same insider on 6/4/2026 (7,064 sh), 6/5/2026 (2,101 sh), and 5/8/2026 (45,481 sh) are noted in the filing.
Financial Impact
Up to $943K in potential insider selling, representing ~0.05% of the $1.9B market cap.
Risk Factors
- Insider selling could marginally pressure the stock if executed quickly.
- Former officer selling post-option exercise is routine, but any acceleration beyond this filing would be a concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005832 |
| Document: 0001950047-26-005832-index.html | 0001950047-26-005832 |
| Document: 0001950047-26-005832.txt | 0001950047-26-005832 |
Track record
20 reports on HRMY
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +14.82% at T+20 after the Jul 16, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $33.21 Now $32.96 −0.75% settles Dec 15
- Nov 4, 202612d ago 8-K Bearish 5/10 No price data
- Nov 4, 202612d ago Press Release Bearish 5/10 Entry $34.42 Now $32.96 +4.23% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.02 Now $32.96 −10.97% settles Dec 2
- Oct 30, 202617d ago 8-K/A Neutral 3/10 Entry $37.91 Now $32.96 −13.06% settles Dec 1
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $38.50 Now $32.96 −14.39% settles Nov 25
- Oct 13, 20264w ago 8-K Neutral 3/10 Entry $37.03 to $33.55 Now $32.96 −10.99% ▼ −9.40% −5.79% vs SPY
- Oct 1, 20266w ago Press Release Neutral 3/10 Entry $39.57 to $38.59 Now $32.96 −16.70% ▼ −2.48% −3.18% vs SPY
- Aug 4, 202614w ago 8-K Bullish 7/10 No price data
- Aug 4, 202614w ago Press Release Bullish 6/10 Entry $38.78 Now $32.96 −15.01% No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers